Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Carmichael › NPI 1972541498
Clinic

Dignity Health

Dignity Health was paid $97.28M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 0450, Emergency room services — 19% of everything it billed.

33Billing provider infoDIGNITY HEALTH
CARMICHAEL, CA 95608
33aNPI1972541498assigned 06/04/2006
33bProvider typeAdult Mental Health Clinic/Center
28Total paid$97.28M
24GClaims1,187,349
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Adult Mental Health Clinic/Center providers in California

Rank by total paid#2 of 99
Median peer was paid$1.44M
This provider vs. median67×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MORISSETTE, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018204,109$15.53M
2019221,870$17.09M
2020154,788$12.18M
2021170,665$13.29M
2022149,406$13.17M
2023156,102$13.94M
2024incomplete130,409$12.08M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 19% 57,027 52,310 $18.63M
36415 Collection of venous blood by venipuncture 13% 65,728 57,827 $13.10M
A9150 Non-prescription drugs 13% 51,093 23,631 $12.62M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.2% 41,408 39,360 $6.96M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.2% 41,797 40,123 $5.07M
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" 5.1% 19,366 10,570 $4.99M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.7% 22,330 21,446 $4.61M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 16,214 15,155 $4.17M
80053 Comprehensive metabolic panel 2.5% 85,784 80,633 $2.45M
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.8% 8,332 7,985 $1.76M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.6% 8,783 8,581 $1.58M
70450 Computed tomography, head or brain; without contrast material 1.5% 10,172 9,860 $1.47M
241 more codes
G0378 Hospital observation service, per hour 1.0% 937 $991K
0682 1.0% 259 $980K
99499 <1% 600 $769K
72125 Computed tomography, cervical spine; without contrast material <1% 3,825 $721K
71045 Radiologic examination, chest; single view <1% 23,376 $713K
71046 Radiologic examination, chest; 2 views <1% 15,372 $647K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 11,382 $574K
Z7502 <1% 14,298 $538K
0762 <1% 121 $502K
0270 <1% 39,451 $476K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 14,153 $471K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 91,572 $470K
0250 <1% 4,367 $455K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,941 $429K
J3490 Unclassified drugs <1% 48,085 $425K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 7,753 $411K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 32,551 $403K
96375 Therapeutic injection; each additional sequential IV push <1% 11,091 $374K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,029 $347K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,580 $276K
S9484 Crisis intervention mental health services, per hour <1% 623 $272K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,863 $266K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,338 $248K
99199 Unlisted special service, procedure or report <1% 1,424 $246K
84484 <1% 24,048 $246K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,811 $246K
70486 <1% 1,527 $240K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 5,114 $217K
80048 Basic metabolic panel (calcium, ionized) <1% 10,922 $214K
73130 <1% 2,813 $208K
0160 <1% 204 $199K
73610 <1% 2,403 $198K
73564 <1% 2,657 $186K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,772 $175K
0360 <1% 235 $174K
81001 <1% 26,034 $173K
73630 <1% 2,844 $168K
87081 <1% 2,741 $155K
73030 <1% 1,921 $142K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,250 $142K
82962 <1% 5,812 $137K
83880 <1% 10,225 $125K
73110 <1% 1,606 $111K
81003 <1% 9,873 $111K
83690 <1% 17,944 $105K
84703 <1% 16,018 $103K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 12,000 $102K
0949 <1% 1,011 $102K
72170 <1% 823 $96K
95811 <1% 462 $91K
86885 <1% 2,638 $86K
96376 <1% 2,540 $85K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,138 $84K
96361 Intravenous infusion, hydration; each additional hour <1% 4,161 $82K
87077 <1% 3,244 $79K
87040 <1% 6,311 $78K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,255 $76K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 425 $75K
93971 <1% 1,677 $75K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 240 $74K
0301 <1% 168 $70K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,864 $68K
10060 <1% 576 $67K
83605 <1% 8,812 $66K
12001 <1% 508 $64K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,724 $63K
76801 <1% 2,085 $62K
73080 <1% 866 $60K
0720 <1% 802 $58K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 136 $57K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 590 $55K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,961 $54K
74018 <1% 969 $53K
A9270 Non-covered item or service <1% 10,310 $52K
72131 <1% 473 $52K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 542 $52K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,181 $51K
73590 <1% 729 $50K
76376 <1% 958 $50K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 1,836 $49K
81025 <1% 3,597 $48K
84702 <1% 4,492 $47K
73090 <1% 769 $47K
0324 <1% 342 $45K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 621 $45K
96112 <1% 280 $45K
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) <1% 57 $45K
87631 <1% 1,042 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,489 $45K
76830 Ultrasound, transvaginal <1% 1,456 $45K
83735 <1% 8,046 $41K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,427 $40K
12011 <1% 382 $40K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,738 $39K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,752 $38K
85610 <1% 9,183 $37K
85730 <1% 6,499 $34K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 127 $33K
Z7610 <1% 4,323 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 12,999 $32K
85027 <1% 7,103 $31K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,871 $29K
0760 <1% 475 $28K
0710 <1% 251 $26K
0121 <1% 12 $25K
82803 <1% 931 $24K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 810 $24K
J8540 Dexamethasone, oral, 0.25 mg <1% 1,106 $24K
86901 <1% 4,800 $22K
94644 <1% 1,380 $22K
J1815 Injection, insulin, per 5 units <1% 1,390 $22K
86880 <1% 1,099 $21K
73502 <1% 354 $20K
0761 <1% 448 $20K
12002 <1% 240 $17K
84443 Thyroid stimulating hormone (TSH) <1% 1,577 $17K
83036 Hemoglobin; glycosylated (A1C) <1% 1,097 $17K
93017 <1% 339 $16K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,527 $16K
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 138 $16K
86141 <1% 2,835 $16K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,072 $15K
85379 <1% 2,648 $15K
86900 <1% 3,769 $14K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,030 $14K
29125 <1% 566 $14K
70551 Magnetic resonance imaging, brain; without contrast material <1% 43 $13K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 34 $13K
73140 <1% 127 $13K
84145 <1% 1,789 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,845 $12K
90715 <1% 1,787 $12K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,022 $11K
80061 Lipid panel <1% 919 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,493 $10K
0305 <1% 28 $10K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,591 $10K
87186 <1% 2,714 $10K
82550 <1% 1,126 $10K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 643 $9K
0272 <1% 105 $8K
76770 <1% 192 $8K
85007 <1% 2,882 $8K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 266 $8K
97750 <1% 595 $7K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,055 $7K
85651 <1% 1,103 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 165 $7K
93970 <1% 98 $7K
J2060 Injection, lorazepam, 2 mg <1% 2,436 $7K
36430 <1% 13 $6K
71250 <1% 52 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,412 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,607 $6K
0370 <1% 21 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,374 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,384 $5K
72100 <1% 93 $5K
99401 <1% 195 $4K
99153 Mod sedat endo service >5yrs <1% 73 $4K
99152 <1% 25 $4K
76870 <1% 137 $4K
Z4301 <1% 157 $4K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 243 $4K
87147 <1% 491 $4K
59025 Fetal non-stress test <1% 277 $4K
J2704 Injection, propofol, 10 mg <1% 670 $4K
J1650 Injection, enoxaparin sodium, 10 mg <1% 590 $3K
0300 <1% 28 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,332 $3K
29515 <1% 128 $3K
64400 <1% 15 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 370 $3K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,843 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,205 $2K
H1003 Prenatal care, at-risk enhanced service; education <1% 109 $2K
82150 <1% 108 $2K
73060 <1% 67 $2K
70491 <1% 15 $2K
84112 <1% 201 $2K
73552 <1% 26 $2K
95816 <1% 12 $2K
0306 <1% 13 $2K
94729 <1% 96 $2K
96367 <1% 136 $2K
70496 <1% 13 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 15 $2K
94726 <1% 93 $2K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 54 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 544 $2K
70498 <1% 25 $2K
0258 <1% 38 $2K
80164 <1% 190 $1K
87420 <1% 55 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 509 $1K
82010 <1% 169 $1K
99070 <1% 124 $1K
J2785 Injection, regadenoson, 0.1 mg <1% 28 $1K
74174 <1% 25 $1K
84132 <1% 306 $1K
88720 <1% 268 $1K
71101 <1% 12 $1K
0750 <1% 26 $907.94
94060 <1% 41 $828.12
87275 <1% 55 $768.28
29105 <1% 12 $677.41
J0690 Injection, cefazolin sodium, 500 mg <1% 298 $654.59
82140 <1% 71 $599.70
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 15 $562.37
84550 <1% 90 $509.69
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 189 $505.89
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 26 $464.81
82553 <1% 45 $464.67
94645 <1% 15 $420.10
84100 <1% 177 $380.58
J1644 Injection, heparin sodium, per 1000 units <1% 123 $344.77
74019 <1% 13 $328.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 66 $273.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $267.96
87276 <1% 55 $246.25
J1630 Injection, haloperidol, up to 5 mg <1% 82 $206.12
J0561 Injection, penicillin g benzathine, 100,000 units <1% 14 $193.40
J1953 Injection, levetiracetam, 10 mg <1% 45 $153.22
70487 <1% 14 $151.72
J3486 Injection, ziprasidone mesylate, 10 mg <1% 13 $117.18
J0360 Injection, hydralazine hcl, up to 20 mg <1% 16 $75.17
C1769 Guide wire <1% 25 $54.12
80178 <1% 15 $35.28
87070 <1% 13 $34.47
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 17 $17.65
J3480 Injection, potassium chloride, per 2 meq <1% 16 $14.56
J1836 Injection, metronidazole, 10 mg <1% 15 $12.19
90686 <1% 15 $8.38
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 14 $6.92
36600 <1% 15 $5.80
84295 <1% 12 $5.18
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 225 $0.58
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 66 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 15 $0.00
41899 Unlisted procedure, dentoalveolar structures 0% 12 $0.00
87205 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORISSETTE, DANIEL (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
Same official

Other billing entities under MORISSETTE, DANIEL

Full network →
ProviderLocationPaid
Dignity HealthSan Bernardino, CA$133.09M
Dignity HealthPhoenix, AZ$126.19M
Dignity HealthBakersfield, CA$109.22M
Dignity HealthMerced, CA$106.54M
Dignity HealthOxnard, CA$96.24M
Dignity HealthRedding, CA$92.21M
Dignity HealthLong Beach, CA$59.98M
Dignity HealthSacramento, CA$45.52M
Dignity HealthFolsom, CA$45.14M
Dignity HealthRed Bluff, CA$39.92M
Dignity HealthSanta Cruz, CA$33.59M
Dignity HealthGilbert, AZ$28.49M
Dignity HealthGlendale, AZ$26.30M
Dignity HealthHenderson, NV$18.73M
Dignity HealthMount Shasta, CA$15.62M
Dignity HealthHenderson, NV$8.52M
Dignity HealthLas Vegas, NV$7.93M
Dignity HealthCamarillo, CA$6.31M
Dignity HealthSanta Maria, CA$5.79M
Dignity HealthCorning, CA$3.24M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.